Corpus Intelligence IC Memo — CRESTWYN BEHAVIORAL HEALTH 2026-04-26 12:48 UTC
IC Memo — CRESTWYN BEHAVIORAL HEALTH
Investment Committee Memorandum | TN | 80 beds | Grade C | EBITDA uplift $1.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CRESTWYN BEHAVIORAL HEALTH

CCN 444025 | nan, TN | 80 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

CRESTWYN BEHAVIORAL HEALTH is a 80-bed community hospital in nan, TN with $19.4M in net patient revenue and a 14.4% operating margin. The hospital serves a payer mix of 10.6% Medicare, 0.0% Medicaid, and 89.4% commercial.

Thesis: Turnaround. Our ML models identify $1.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 14.4% to 21.8% (+736bps).

Net Revenue HCRIS$19.4M
Current EBITDA COMPUTED$2.8M
Operating Margin COMPUTED14.4%
Occupancy HCRIS87.2%
Revenue / Bed COMPUTED$243K
Net-to-Gross HCRIS43.4%
Distress Probability MLnan%

2. Market Context & Competitive Position

141
TN Hospitals
-0.6%
State Median Margin
60
Comparable Hospitals

TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 14.4% places it above the state median. Among 60 size-comparable peers (40-160 beds), the median margin is -0.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (40-160), prioritizing same-state peers. 60 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CRESTWYN BEHAVIORAL HEALTH (Target)TN80$19.4M14.4%
BLOUNT MEMORIAL HOSPITALTN145$326.0M-8.5%
METRO NASHVILLE GENERAL HOSPITTN114$287.4M48.9%
TRISTAR HENDERSONVILLE MEDICALTN129$208.6M41.5%
TRISTAR STONECREST MEDICAL CENTN115$190.0M39.5%
BAPTIST MEM HOSPITAL TIPTON COTN48$179.0M-5.8%
SUMNER REGIONAL MEDICAL CENTERTN138$161.9M-2.7%
VANDERBILT WILSON COUNTY HOSPITN113$158.7M-7.1%
METHODIST MEDICAL CENTERTN157$153.6M-9.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$408K+210bp18mo
Cost to Collect4.5%2.5%$389K+200bp12mo
Denial Rate Reduction12.0%6.5%$385K+198bp12mo
A/R Days Reduction5200.0%3800.0%$237K+122bp9mo
Clean Claim Rate88.0%96.0%$12K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$408K
Cost to Collect
$389K
Denial Rate Reduction
$385K
A/R Days Reduction
$237K
Clean Claim Rate
$12K
Total EBITDA Uplift$1.4M
Current EBITDA$2.8M
+ RCM Uplift+$1.4M
Pro Forma EBITDA$4.2M
Current Margin14.4%
Pro Forma Margin21.8%
WC Released (1x)$746K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$4.3M$32.8M7.60x50.0%
Base (11x exit)10.0x11.0x$4.3M$37.5M8.69x54.1%
Bull Case9.0x11.0x$3.9M$43.6M11.23x62.2%
Bull (12x exit)9.0x12.0x$3.9M$48.8M12.55x65.8%
Bear Case11.0x10.0x$4.8M$24.3M5.11x38.6%
Bear (11x exit)11.0x11.0x$4.8M$28.2M5.95x42.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 60 hospitals with 40-160 beds
  • Same-state prioritization (n=61)
  • Comp margins: P25=-10.8% / P50=-0.5% / P75=12.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.